{"id":396843,"date":"2025-03-15T14:00:00","date_gmt":"2025-03-15T13:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/lancement-de-letude-de-phase-3-sauvage-quantum-pour-les-patients-atteints-de-lma-flt3-itd-negative\/"},"modified":"2025-03-15T14:09:06","modified_gmt":"2025-03-15T13:09:06","slug":"lancement-de-letude-de-phase-3-sauvage-quantum-pour-les-patients-atteints-de-lma-flt3-itd-negative","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/lancement-de-letude-de-phase-3-sauvage-quantum-pour-les-patients-atteints-de-lma-flt3-itd-negative\/","title":{"rendered":"Lancement de l&#8217;\u00e9tude de phase 3 sauvage QuANTUM pour les patients atteints de LMA FLT3-ITD-n\u00e9gative"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>La leuc\u00e9mie my\u00e9lo\u00efde aigu\u00eb (LMA) est l&#8217;une des formes les plus courantes de leuc\u00e9mie chez l&#8217;adulte. \u00c0 ce jour, il n&#8217;existe pas d&#8217;inhibiteurs du FLT3 approuv\u00e9s pour les patients atteints de LMA FLT3-ITD n\u00e9gative, bien qu&#8217;une activation permanente du r\u00e9cepteur FLT3 puisse \u00e9galement contribuer \u00e0 la progression de la maladie dans cette population de patients. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Flancement-de-letude-de-phase-3-sauvage-quantum-pour-les-patients-atteints-de-lma-flt3-itd-negative%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>La leuc\u00e9mie my\u00e9lo\u00efde aigu\u00eb (LMA) est l&#8217;une des formes les plus courantes de leuc\u00e9mie chez l&#8217;adulte. \u00c0 ce jour, il n&#8217;existe pas d&#8217;inhibiteurs du FLT3 approuv\u00e9s pour les patients atteints&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Flancement-de-letude-de-phase-3-sauvage-quantum-pour-les-patients-atteints-de-lma-flt3-itd-negative%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":396845,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Leuc\u00e9mie my\u00e9lo\u00efde aigu\u00eb  ","footnotes":""},"category":[11527,11531,11373,11545,11389,11549],"tags":[81788,81886],"powerkit_post_featured":[],"class_list":["post-396843","post","type-post","status-publish","format-standard","has-post-thumbnail","category-etudes","category-formation-continue","category-hematologie","category-marche-medecine","category-oncologie","category-rx-fr","tag-leucemie-myeloide-aigue","tag-quizartinib-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-19 22:41:48","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":396837,"slug":"e-iniziato-lo-studio-di-fase-3-quantum-wild-per-i-pazienti-con-aml-flt3-itd-negativa","post_title":"\u00c8 iniziato lo studio di fase 3 QuANTUM wild per i pazienti con AML FLT3-ITD-negativa","href":"https:\/\/medizinonline.com\/it\/e-iniziato-lo-studio-di-fase-3-quantum-wild-per-i-pazienti-con-aml-flt3-itd-negativa\/"},"pt_PT":{"locale":"pt_PT","id":396831,"slug":"iniciado-o-ensaio-quantum-wild-de-fase-3-em-doentes-com-lma-flt3-itd-negativa","post_title":"Iniciado o ensaio QuANTUM wild de fase 3 em doentes com LMA FLT3-ITD-negativa","href":"https:\/\/medizinonline.com\/pt-pt\/iniciado-o-ensaio-quantum-wild-de-fase-3-em-doentes-com-lma-flt3-itd-negativa\/"},"es_ES":{"locale":"es_ES","id":396824,"slug":"se-inicia-el-ensayo-quantum-wild-de-fase-3-para-pacientes-con-lma-flt3-itd-negativa","post_title":"Se inicia el ensayo QuANTUM wild de fase 3 para pacientes con LMA FLT3-ITD negativa","href":"https:\/\/medizinonline.com\/es\/se-inicia-el-ensayo-quantum-wild-de-fase-3-para-pacientes-con-lma-flt3-itd-negativa\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/396843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=396843"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/396843\/revisions"}],"predecessor-version":[{"id":397223,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/396843\/revisions\/397223"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/396845"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=396843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=396843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=396843"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=396843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}